TorreyPines Therapeutics Inc

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	47
ISBN Number	not applicable
Product Code	DAT11492

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

TorreyPines Therapeutics is a San-Diego-based biotechnology company formed through a reverse-merger with publicly-held Axonyx in October 2006. Previously known as Neurogenetics, TorreyPines is focused on the discovery and development of novel drug candidates to treat diseases such as chronic pain, migraine, and cognitive disorders.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

The company's clinical product pipeline folio includes: Phenserine being developed for Alzheimer's disease (Phase III); Tezampanel for migraine (Phase II); NGX267 for CIAS (Phase I) and dry mouth (Phase II); NGX426 for migraine (Phase I) and neuropathic pain (Phase I); and Posiphen for Alzheimer's disease (Phase I). The company recognizes revenues in the form license fees and research funding from its collaborators pursuant to the agreements entered. These primarily include: revenues received from Eisai for the discovery of genes responsible for late onset Alzheimer's disease, and from Life Science Research Israel (LSRI) for the development NGX292 indicated for Alzheimer disease.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Torreypines - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table of Tables
- Table 1: Torreypines - Key Facts
- Table 2: Torreypines - Locations and Subsidiaries
- Table 3: Torreypines - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Torreypines - Key Events Impacting Share Price Performance
- Table 5: Torreypines - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Torreypines - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 7: Torreypines - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Torreypines - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Torreypines - in-House Pipeline Products
- Table 10: Torreypines - Collaboration Products
- Table 11: Torreypines - Forecast Sales, 2006-2010 ($ Mn)
- Table 12: Torreypines - Key Competitors
- Table 13: Torreypines - Key Suppliers
- Table 14: Torreypines - Key Clients
- Table 15: Torreypines - Key Shareholders
- Table 16: Torreypines - SWOT Analysis Summary
- Table 17: Torreypines - Value Chain Analysis
- Table 18: Torreypines - Scorecard
- Table 19: Torreypines - Key Employees
- Table 20: Torreypines - Financial and Operational Overview